-
Registration to Viral Infections & Inflammation Workshop 2024 is now open!
-
This year the format of the workshop is virtual. You can join the workshop from anywhere.
-
The abstract portal is now closed.
Viral Infections & Inflammation Workshop 2024
Related Enduring Materials
Day 1 - Thursday, 26 September
Day 2 - Friday, 27 September
What's New
About this Program
The Viral Infections & Inflammation Workshop 2024 took place as a virtual meeting from 26 - 27 September 2024.
This workshop brings together basic, translational, and clinical researchers to disseminate the latest knowledge in this area and fuel discussion on the many remaining unknowns in order to catalyze future research.
Acute and chronic effects of viral diseases often involve immune-mediated responses, including inflammation, immune activation, and autoimmunity. Long-COVID immunopathogenesis is complex but its understanding is advancing rapidly. The consequences of immune-mediated damage in long COVID share similarities (and differences) with other post-viral diseases like Ebola and Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). In the case of HIV, ongoing activation of the inflammatory response is a major concern, and immune reconstitution remains limited in some patients even long after treatment initiation. In addition to SARS-CoV-2 and HIV, other viral infections such as CMV are known to result in inflammation-related pathology. Viruses can also trigger autoimmunity. Epstein-Barr Virus is tightly linked with the onset of Multiple Sclerosis through several autoimmune mechanisms. Viral encephalitis also often has an autoimmune background. Although these few examples illustrate different viral infections with distinct clinical consequences, underlying mechanisms that drive inflammatory complications may be common. Which plausible mechanisms are at play?
Persistent inflammation, mucosal damage, coagulopathy, autoimmunity, and immune dysfunction are putative pieces of the puzzle. Common underlying mechanisms imply the possibility of employing similar therapeutic interventions, such as neutralizing antibodies, antiviral drugs, and therapeutic vaccines to eliminate the persistent virus or anti-inflammatory drugs to ameliorate chronic inflammation. Therapeutic interventions must often target both ends of the virus-immune system spectrum. Immune therapies targeting the inflammasome or virus-specific CAR-T cells, among others, are advancing toward the cure of different acute and chronic viral diseases.
Are you interested in hearing the progress in elucidating this remaining unmet need? Find out what we have learned so far, what the gaps are, and what we can do to address those in the future.
General Information
- (Clinical) virologists;
- Immunologists;
- Microbiologists; and
- Researchers
-Provide a global platform to exchange knowledge across different disciplines involved in research on mechanisms of virus-mediated inflammation;
- Gather basic, translational, and clinical researchers to stimulate discussion on remaining unknowns;
- Foster future collaborations among participants;
- Translate the data into clinical guidance; and
- Increase the visibility of junior investigators and their research thereby facilitating a generation of future leaders in the field.
- Outline viral infections associated with aberrant inflammation and describe the underlying mechanism and clinical manifestations;
- Summarize the latest clinical data on potential therapeutic options; and
- Identify post-infection comorbidities and reflect on management options for these comorbidities.
Practical Information
We trust that the following information will assist you in organizing your participation for the Viral Infections and Inflammation Workshop 2024.
Any individual who feels discriminated against, harassed, disrespected, or marginalized is encouraged to report the incident(s) to VE and AME via info@amededu.com or to one of our on-site personnel.
Any participant who is found to have exhibited any inappropriate conduct or behavior against others may be removed from the program.
Organizing Committee
The members of the Organizing Committee are a group of carefully selected experts and inspirational leaders in their respective fields. They meet frequently to discuss the scientific program of the workshop, identify interesting topics and candidate speakers, and review all submitted abstracts.
Scientific Program Coordinator
Support Our Initiative
Financial backing helps us deliver an impactful meeting experience to the benefit of healthcare professionals and researchers interested in this field.
This collaboration plays a vital role in both the organizational as well as scientific success of the program.
To show your commitment to the cause, get in touch with us for a tailored
support package by contacting Ms. Gi Gi Lam at Gigi.Lam@amededu.com.
Benefits of Support
By supporting this program, we can offer the following advantages for your company.* Please contact us for the most recent support level benefits for this program.
- Symposium opportunities
- Non-commercial interviews with company representatives
- Verbal acknowledgement during the program
- Discounted and complimentary registrations for your representatives
- Company acknowledgement on digital meeting materials including but not limited to newsletters, flyers, the streaming platform, and our website
- Company acknowledgement on printed meeting materials including but not limited to banners and the program book
- Digital and printed advertising opportunities
- Social media shout-outs
- Logo on the conference bag
*Subject to the support level.
2023 Highlights
Hear Prof. Roger Paredes, MD, PhD (Hospital Germans Trias & IrsiCaixa AIDS Research Institute, Spain) deliver an insightful summary for clinicians on the take-home messages from the 2nd edition of the Workshop!